Identifying Vulnerable CoronAry PLaqUes With Artificial IntElligence-assisted CT Angiography (VALUE)
Development and Validation of Multi-scale Deep Neural Network-Based CT Intelligent Diagnosis System for Coronary Vulnerable Plaques: A Chinese Multicenter Study
The goal of this observational study is to develop an automatic whole-process AI model to detect, quantify, and characterize plaques using coronary CT angiography in coronary artery disease patients. The main questions it aims to answer are:
- Whether the AI model enables to detect and quantify coronary plaques compared with intravascular ultrasound or expert readers;
- Whether the AI model enables to identify vulnerable plaques using intravascular ultrasound or optical coherence tomography as the reference standard.
- Whether the AI model enables to predict future adverse cardiac events in a large cohort of 10,000 patients with non-obstructive CAD.
- Whether the AI model enables to influnece downstream clincial decision-making.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Coronary artery disease (CAD) remains the leading cause of death worldwide. Atherosclerotic plaques play a pivotal role in CAD-related patient mortality. Thus, the detection, quantification, and characterization of coronary plaques are clinically significant for early prevention and interventions for CAD.
Coronary CT angiography (CCTA) has emerged as a robust noninvasive tool for the evaluation of CAD. In clinical practice, the coronary plaque assessment is performed by a time-consuming manual process dependent on the clinician's experience and subjective visual interpretation. With the development of artificial intelligence, many automatic computer-aided methods have been proposed to post-process the CCTA images. However, previously proposed algorithms of plaque evaluation were not developed based on intravascular ultrasound (IVUS) or optical coherence tomography (OCT), which were regarded as the gold reference for plaque evaluation. Thus, we aimed to develop a deep learning model in a whole-process automatic and intelligent system on CCTA to detect, quantify, and characterize plaques using IVUS or OCT as reference standard. Then we will work on the validation in different clinical scenarios: (1) Validation of the accuracy of the new deep learning model; (2) Prognosis of the model in different populations with CAD; (3) Impact of the model on guiding clincial therapies.
The main questions it aims to answer are:
- Whether the AI model enables to detect and quantify coronary plaques compared with intravascular ultrasound or expert readers;
- Whether the AI model enables to identify vulnerable plaques using IVUS or OCT as the reference standard.
- Whether the AI model enables to predict future adverse cardiac events in a large cohort of 10,000 patients with non-obstructive coronary artery disease (China CT-FFR study 2).
- Whether the AI model enables to influnece downstream clincial decision-making in real-world clincial practice.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
Jiangsu
-
Nanjing, Jiangsu, China, 210018
- Research Institute Of Medical Imaging Jinling Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Intravascular imaging (including intravascular ultrasound or optical coherence tomography) was performed within 3 months after CCTA;
- No change in medications or clinical symptoms during CCTA and intravascular imaging examinations;
- Coronary artery diameter stenosis of 30% to 90% on invasive coronary imaging.
Exclusion Criteria:
- Image quality of CCTA or intravascular US was inadequate to analyze;
- Intravascular imaging was performed after percutaneous coronary intervention (PCI) or pre-dilation of the target lesions;
- Lesions could not be co-registered between CCTA and intravascular US;
- Missing CCTA or intravascular US data
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients who underwent coronary CT angiography and intravascular ultrasound within 3 months
|
Coronary artery disease patients first underwent CCTA and then intravascular imaging test within 3 months.
|
|
Patients who underwent coronary CT angiography and optical coherence tomography within 3 months
|
Coronary artery disease patients first underwent CCTA and then intravascular imaging test within 3 months.
|
|
Patients who underwent coronary CT angiography because of suspected or known coronary artery disease
|
Plaques on coronary CT angiography (CCTA) were quantified and characterized using the developed AI model.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Sensitivity and specificity of AI-assisted coronary CT angiography on identifying vulnerable plaques compared to intravascular imaging
Time Frame: 1 day
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Overall coronary plaque detection rate using intravascular ultrasound as reference standard
Time Frame: 1 day
|
1 day
|
|
Total plaque volume
Time Frame: 1 day
|
1 day
|
|
Changes in medical management following the addition of the AI model compared with routine CCTA results alone.
Time Frame: 90 days
|
90 days
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Longjiang Zhang, MD, Jinling Hospital, Medical School of Nanjing University, Nanjing,China
Publications and helpful links
General Publications
- Gaba P, Gersh BJ, Muller J, Narula J, Stone GW. Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient: implications for patient care and future research. Nat Rev Cardiol. 2023 Mar;20(3):181-196. doi: 10.1038/s41569-022-00769-8. Epub 2022 Sep 23.
- Zhou F, Chen Q, Luo X, Cao W, Li Z, Zhang B, Schoepf UJ, Gill CE, Guo L, Gao H, Li Q, Shi Y, Tang T, Liu X, Wu H, Wang D, Xu F, Jin D, Huang S, Li H, Pan C, Gu H, Xie L, Wang X, Ye J, Jiang J, Zhao H, Fang X, Xu Y, Xing W, Li X, Yin X, Lu GM, Zhang LJ. Prognostic Value of Coronary CT Angiography-Derived Fractional Flow Reserve in Non-obstructive Coronary Artery Disease: A Prospective Multicenter Observational Study. Front Cardiovasc Med. 2022 Jan 31;8:778010. doi: 10.3389/fcvm.2021.778010. eCollection 2021.
- Follmer B, Williams MC, Dey D, Arbab-Zadeh A, Maurovich-Horvat P, Volleberg RHJA, Rueckert D, Schnabel JA, Newby DE, Dweck MR, Guagliumi G, Falk V, Vazquez Mezquita AJ, Biavati F, Isgum I, Dewey M. Roadmap on the use of artificial intelligence for imaging of vulnerable atherosclerotic plaque in coronary arteries. Nat Rev Cardiol. 2024 Jan;21(1):51-64. doi: 10.1038/s41569-023-00900-3. Epub 2023 Jul 18.
- Chen Q, Zhou F, Xing W, Xu Y, Hu S, Pan T, Cao W, Guo L, Shi Y, Luo S, Xu L, Zhang J, Zhang S, Zheng C, Yang Z, Qiao HY, Guo B, Liu T, Xu P, Xu W, Zhong J, Xie G, Tao X, Lu G, Tang CX, Zhang JJ, Zhang LJ; China VALUE Study Group. A Fully Automated Deep Learning Model for Quantifying Coronary Plaque at Coronary CT Angiography. Radiology. 2026 Apr;319(1):e251967. doi: 10.1148/radiol.251967.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023DZKY-058-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.